A novel mutation with Ins C (882-883) of the factor X gene in a Taiwanese Chinese factor X–deficient family

• References

• 1 Telfer TP, Denson KW, Wright DR. A “new coagulation” defect. Br J Haematol 1956; 02: 308-16.
• 2 Cooper DN, Millar DS, Wacey A. et al. Merited factor X deficiency: Molecular genetics and pathophysiology. Thromb Haemost 1997; 78: 161-72.
• 3 Reddy SV, Zhou ZQ, Rao KJ. et al. Molecular characterization of human factor X_{San Antonio} . Blood 1989; 74: 1486-90.
• 4 Miyata T, Kojima T, Suzuki K. et al. Factor Nagoya 1 and Nagoya 2: a CRM⁻ factor X deficiency and a dysfunctional CRM⁺ factor deficiency characterized by substitution of Arg 306 by Cys and of Gly 366 by Ser, respectively. Thromb Haemost 1998; 79: 486-90.
• 5 Millar DS, Elliston L, Deex P. et al. Molecular analysis of the genotype-phenotype relationship in factor X deficiency. Hum Genet 2000; 106: 249-57.
• 6 Simioni P, Vianello F, Kalafatis M. et al. dysfunctional factor X(factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (del C556) and missense mutation (Lys⁴⁰⁸→Asn) in the factor X gene. study of an Italian family. Thromb Res 2001; 101: 219-30.
• 7 Peyvandi F, Duga S, Akhavan S. et al. Rare coagulation deficiencies. Haemophilia 2002; 08: 308-21.
• 8 Shen MC, Lin JS, Lin SW. et al. Novel mutations in the factor VII gene of Taiwanese factor VII-deficient patients. Br J Haematol 2001; 112: 566-71.
• 9 Messier TL, Pittman DD, Long GL. et al. Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation factor X. Gene 1991; 99: 291-4.